Viewing StudyNCT00129337



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00129337
Status: COMPLETED
Last Update Posted: 2011-03-01
First Post: 2005-08-10

Brief Title: Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
Sponsor: Peregrine Pharmaceuticals
Organization: Peregrine Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Tumors
Keywords:
Name View
refractory advanced solid tumor malignancy View
monoclonal antibody View
phase 1 View
solid tumor View
anti-angiogenesis View